Aehr Test Systems (NASDAQ:AEHR) Shorted Shares Increased By 129.09%


The stock of Aehr Test Systems (NASDAQ:AEHR) registered an increase of 129.09% in short interest. AEHR’s total short interest was 37,800 shares in September as published by FINRA. Its up 129.09% from 16,500 shares, reported previously. With 144,500 shares average volume, it will take short sellers 0 days to cover their AEHR’s short positions. The short interest to Aehr Test Systems’s float is 0.38%. About 5,652 shares traded hands. Aehr Test Systems (NASDAQ:AEHR) has risen 108.85% since February 8, 2016 and is uptrending. It has outperformed by 92.36% the S&P500.

Aehr Test Systems is engaged in the designing, manufacturing and marketing of advanced test and burn-in products to the semiconductor manufacturing industry. The company has a market cap of $29.29 million. The Firm makes and markets full wafer contact test systems, test during burn-in systems, test fixtures, die carriers and related accessories. It currently has negative earnings. The Company’s principal products are the Advanced Burn-In and Test System , the FOX full wafer contact parallel test and burn-in systems, WaferPak full wafer contactor, the DiePak carrier and test fixtures.

The institutional sentiment decreased to 0.5 in Q2 2016. Its down 0.50, from 1 in 2016Q1. The ratio fall, as 2 funds sold all Aehr Test Systems shares owned while 4 reduced positions. 1 funds bought stakes while 2 increased positions. They now own 289,127 shares or 9.15% less from 318,256 shares in 2016Q1.

Minerva Advisors Llc holds 0.06% of its portfolio in Aehr Test Systems for 58,702 shares. Blackrock Fund Advisors owns 2,586 shares or 0% of their US portfolio. Moreover, Citadel Advisors Llc has 0% invested in the company for 12,012 shares. The Massachusetts-based Geode Capital Management Llc has invested 0% in the stock. Morgan Stanley, a New York-based fund reported 19,669 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Reply